Voie d'immunisation et séquence d'administration de l ... - TEL

tel-00827710, version 1 - 29 May 2013
5. References
1. Arens R, Schoenberger SP (2010) Plasticity in programming of effector and memory CD8
T-cell formation. Immunol Rev 235 (1):190-205. doi:10.1111/j.0105-2896.2010.00899.x
2. Schumacher TNM, Gerlach C, Heijst JWJv (2010) Mapping the life histories of T cells.
Nature Publishing Group 10 (9):621-631. doi:10.1038/nri2822
3. Coulie PG, Karanikas V, Lurquin C, Colau D, Connerotte T, Hanagiri T, Van Pel A, Lucas
S, Godelaine D, Lonchay C, Marchand M, Van Baren N, Boon T (2002) Cytolytic T-cell
responses of cancer patients vaccinated with a MAGE antigen. Immunol Rev 188:33-42
4. Lamoreaux L, Roederer M, Koup R (2006) Intracellular cytokine optimization and standard
operating procedure. Nat Protoc 1 (3):1507-1516. doi:10.1038/nprot.2006.268
5. Sun Y, Iglesias E, Samri A, Kamkamidze G, Decoville T, Carcelain G, Autran B (2003) A
systematic comparison of methods to measure HIV-1 specific CD8 T cells. J Immunol
Methods 272 (1-2):23-34
6. Altman JD, Moss PA, Goulder PJ, Barouch DH, McHeyzer-Williams MG, Bell JI,
McMichael AJ, Davis MM (1996) Phenotypic analysis of antigen-specific T lymphocytes.
Science 274 (5284):94-96
7. Altman JD, Davis MM (2003) MHC-peptide tetramers to visualize antigen-specific T cells.
Curr Protoc Immunol Chapter 17:Unit 17.13. doi:10.1002/0471142735.im1703s53
8. Davis MM, Altman JD, Newell EW (2011) Interrogating the repertoire: broadening the
scope of peptide–MHC multimer analysis. Nature Reviews Immunology 11 (8):551-558.
doi:10.1038/nri3020
9. Klenerman P, Cerundolo V, Dunbar PR (2002) TRACKING T CELLS WITH
TETRAMERS: NEW TALES FROM NEW TOOLS. Nature Reviews Immunology 2
(4):263-272. doi:10.1038/nri777
10. Romero P, Valmori D, Pittet MJ, Zippelius A, Rimoldi D, Lévy F, Dutoit V, Ayyoub M,
Rubio-Godoy V, Michielin O, Guillaume P, Batard P, Luescher IF, Lejeune F, Liénard D,
Rufer N, Dietrich P-Y, Speiser DE, Cerottini J-C (2002) Antigenicity and immunogenicity
of Melan-A/MART-1 derived peptides as targets for tumor reactive CTL in human
melanoma. Immunol Rev 188:81-96
224